BackNovavax Overview

Novavax Inventory

Track Novavax's inventory ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$10.01M
↓ 2.29% YoYΔ $-234000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Novavax Inventory History

Loading

Novavax vs. peers: Inventory Comparison

Loading

Novavax Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Novavax (NVAX) FAQ

Novavax (NVAX) currently reports a inventory of $10M as of June 2026. That compares with $10M in the prior-year period — down 2.3% year over year. Use the charts on this page to explore Novavax's inventory history and peer comparisons.

Novavax's inventory decreased from $10M to $10M — a 2.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novavax reported $10M in inventory as of June 2026. That compares with $10M in the prior-year period — down 2.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Novavax, and consider following NVAX for alerts when major investors trade the stock.

Novavax is classified in the Healthcare sector. On inventory, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVAX with unrelated industries.